Literature DB >> 16020514

Three pathways to mature macrophages in the early mouse yolk sac.

Julien Y Bertrand1, Abdelali Jalil, Michèle Klaine, Steffen Jung, Ana Cumano, Isabelle Godin.   

Abstract

The existence of macrophages (Mphi) of yolk-sac (YS) origin has been reported in all vertebrate models. However, the nature of their precursors and pathways of differentiation have not been elucidated. Phenotypic and differentiation potential analyses of YS at 7.5 to 10 postcoital days (dpc), performed in CX3CR1(GFP) embryos, allowed us to discern 3 independent Mphi populations. A first transient wave consisted of mature, maternal-derived Mphipresent as early as 7.5 to 8 dpc. A second wave of committed Mphi precursors arose at 8 dpc (2-4 somite stage) and was followed by a third wave of erythromyeloid precursors (4-6 somite stage). Both types of precursors displayed similar phenotypes and gave rise to CX3CR1/green fluorescent protein (GFP)-positive Mphi, but differed by their differentiation potential, at the clonal level. The combined data of phenotypic, gene-expression, and in situ analyses allowed us to conclude that the previously named "primitive Mphi" corresponded to a mixture of the first transient wave and committed Mphi precursors. Both YS-derived precursors followed a developmental pathway common to adult Mphi and could be qualified as definitive.

Entities:  

Mesh:

Year:  2005        PMID: 16020514     DOI: 10.1182/blood-2005-02-0461

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  119 in total

Review 1.  RUNX1 and the endothelial origin of blood.

Authors:  Long Gao; Joanna Tober; Peng Gao; Changya Chen; Kai Tan; Nancy A Speck
Journal:  Exp Hematol       Date:  2018-10-31       Impact factor: 3.084

Review 2.  Perspectives on antigen presenting cells in zebrafish.

Authors:  Kanako L Lewis; Natasha Del Cid; David Traver
Journal:  Dev Comp Immunol       Date:  2014-03-29       Impact factor: 3.636

3.  CD41+ cmyb+ precursors colonize the zebrafish pronephros by a novel migration route to initiate adult hematopoiesis.

Authors:  Julien Y Bertrand; Albert D Kim; Shutian Teng; David Traver
Journal:  Development       Date:  2008-04-16       Impact factor: 6.868

Review 4.  Transcriptional programming of human macrophages: on the way to systems immunology.

Authors:  Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2015-04-16       Impact factor: 4.599

Review 5.  Origin of microglia: current concepts and past controversies.

Authors:  Florent Ginhoux; Marco Prinz
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-07-01       Impact factor: 10.005

Review 6.  Mechanisms and significance of microglia-axon interactions in physiological and pathophysiological conditions.

Authors:  Yuki Fujita; Toshihide Yamashita
Journal:  Cell Mol Life Sci       Date:  2021-01-28       Impact factor: 9.261

7.  Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis.

Authors:  I Cortegano; P Melgar-Rojas; L Luna-Zurita; M Siguero-Álvarez; M A R Marcos; M L Gaspar; J L de la Pompa
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

Review 8.  Erythro-myeloid progenitors: "definitive" hematopoiesis in the conceptus prior to the emergence of hematopoietic stem cells.

Authors:  Jenna M Frame; Kathleen E McGrath; James Palis
Journal:  Blood Cells Mol Dis       Date:  2013-10-02       Impact factor: 3.039

9.  Definitive hematopoiesis initiates through a committed erythromyeloid progenitor in the zebrafish embryo.

Authors:  Julien Y Bertrand; Albert D Kim; Emily P Violette; David L Stachura; Jennifer L Cisson; David Traver
Journal:  Development       Date:  2007-10-24       Impact factor: 6.868

10.  Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network.

Authors:  Laurent Chorro; Aurélien Sarde; Mei Li; Kevin J Woollard; Pierre Chambon; Bernard Malissen; Adrien Kissenpfennig; Jean-Baptiste Barbaroux; Richard Groves; Frédéric Geissmann
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.